Yoshihiro Kumagae

In vivo conversion of racemized β‐amyloid ([<scp>D</scp>‐Ser²⁶]Aβ1–40) to truncated and toxic fragments ([<scp>D</scp>‐Ser²⁶]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

Takekazu Kubo, Satoko Nishimura, Yoshihiro Kumagae et al. · Journal of Neuroscience Research · 2002 · 241 citations

β-Amyloid Racemized at the Ser²⁶Residue in the Brains of Patients with Alzheimer Disease: Implications in the Pathogenesis of Alzheimer Disease

Takekazu Kubo, Yoshihiro Kumagae, Carol A. Miller et al. · Journal of Neuropathology & Experimental Neurology · 2003 · 68 citations

Molecular Biology, Neurochemical Biomarkers, Alzheimer's Disease +16

Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia

Yoshiki Matsui, Yoshihiro Kumagae · Neuroscience Letters · 1991 · 54 citations

Transient Forebrain Ischemia, Striatal Neuronal Necrosis, Brain Injury +16

A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in BDF1 mice

Hiroshi Karasawa, Seiko Nagata-Goto, Kiyosumi Takaishi et al. · Metabolism · 2009 · 51 citations

Obesity, Nutrition, Metabolic Syndrome +13

Pharmacological Characterization of RS-1259, an Orally Active Dual Inhibitor of Acetylcholinesterase and Serotonin Transporter, in Rodents: Possible Treatment of Alzheimer’s Disease

Yasuyuki Abe, Atsushi Aoyagi, Takao Hara et al. · Journal of Pharmacological Sciences · 2003 · 49 citations · Full text